MBRX
MOLECULIN BTECH (MBRX)
NASDAQ
$2.43-$0.03 (-1.26%)
Price as of Jun 03, 2026 6:43 PM EDT
  • $14.9M
    Market Cap
  • -88.29%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-15.9M
-10.37%
-17.7M
-9.02%
-19.5M
+2.74%
-19.0M
+31.56%
Depreciation and Amortization Expense
90,000
-28.57%
126,000
-0.79%
127,000
-2.31%
130,000
-20.73%
Total Operating Expenses
25.1M
-5.77%
26.6M
-10.09%
29.6M
-3.29%
30.6M
+33.40%
Operating Profit
-25.1M
-5.77%
-26.6M
-10.09%
-29.6M
-3.29%
-30.6M
+33.40%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-20,000
-146.51%
43,000
-10.42%
48,000
+20.00%
40,000
0.00%
Income before Taxes
-33.7M
+26.36%
-26.6M
-10.09%
-29.6M
-3.29%
-30.6M
+33.40%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-33.6M
+54.21%
-21.8M
-26.89%
-29.8M
+2.56%
-29.0M
+82.62%
Net Income from Continuing Operations Applicable to Common
-33.7M
+54.68%
-21.8M
-26.89%
-29.8M
+2.56%
-29.0M
+82.62%
Basic EPS and Net Income
-28.42
+349.68%
-6.32
-58.06%
-15.07
+1,392.08%
-1.01
+71.19%
Diluted EPS and Net Income
-28.42
+349.68%
-6.32
-58.06%
-15.07
+1,392.08%
-1.01
+71.19%
Basic Weighted Average Shares
1.2M
-65.59%
3.4M
+74.28%
2.0M
-93.09%
28.6M
+6.43%
Diluted Weighted Average Shares
1.2M
-65.59%
3.4M
+74.28%
2.0M
-93.09%
28.6M
+6.43%
Balance Sheet
Cash and Cash Equivalents
8.9M
+107.53%
4.3M
-81.83%
23.6M
-45.42%
43.1M
-39.15%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.9M
+107.53%
4.3M
-81.83%
23.6M
-45.42%
43.1M
-39.15%
Total Current Assets
9.7M
+86.48%
5.2M
-80.23%
26.3M
-42.38%
45.6M
-37.11%
Accumulated Depreciation
1.1M
+7.63%
1.0M
+14.06%
896,000
N/A
N/A
N/A
Property and Plant and Equipment and Net
78,000
-50.94%
159,000
-41.54%
272,000
-1.09%
275,000
-18.64%
Total Long-Term Assets
900,000
+466.04%
159,000
-41.54%
272,000
-1.09%
275,000
-18.64%
Total Assets
22.1M
+30.73%
16.9M
-55.71%
38.2M
-33.45%
57.4M
-31.71%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
0
N/A
0
N/A
0
-100.00%
86,000
-21.10%
Total Current Liabilities
6.9M
+27.90%
5.4M
-21.36%
6.8M
+41.42%
4.8M
+33.05%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
266,000
-95.24%
5.6M
+4.84%
5.3M
+1,193.45%
412,000
-72.07%
Total Liabilities
7.1M
-34.95%
10.9M
-9.86%
12.1M
+132.15%
5.2M
+2.63%
Retained Earnings
-206.0M
+34.29%
-153.4M
+16.56%
-131.6M
+29.23%
-101.8M
+39.86%
Total Stockholders Equity
15.0M
+150.98%
6.0M
-77.07%
26.1M
-50.04%
52.2M
-33.93%
Total Shares Outstanding
3.2M
-5.32%
3.4M
+51.69%
2.2M
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-22.7M
-4.72%
-23.9M
-0.99%
-24.1M
-12.80%
-27.6M
+45.84%
Capital Expenditures
0
-100.00%
13,000
-89.52%
124,000
+85.07%
67,000
+252.63%
Cash from Investing Activities
0
+100.00%
-13,000
-89.52%
-124,000
+85.07%
-67,000
+252.63%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
27.3M
+488.65%
4.6M
-0.34%
4.7M
+20,321.74%
-23,000
-100.03%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-171.88%
+117.75%
-78.93%
+26.80%
-62.25%
+51.76%
-41.02%
+45.98%
Return on Equity
-319.85%
+135.53%
-135.80%
+78.51%
-76.07%
+71.91%
-44.25%
+34.69%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.41
+45.81%
0.97
-74.86%
3.86
-59.25%
9.46
-52.73%
Cash Ratio
1.30
+62.26%
0.80
-76.90%
3.46
-61.40%
8.95
-54.26%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow